Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up.

Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Groeneweg M, de Bruijne FH, Hillegers MHJ, Escher JC, Utens EMWJ.

J Clin Psychol Med Settings. 2019 Sep 10. doi: 10.1007/s10880-019-09649-9. [Epub ahead of print]

PMID:
31506853
2.

IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4+ T cells: relevance to inflammatory bowel disease.

Veenbergen S, Li P, Raatgeep HC, Lindenbergh-Kortleve DJ, Simons-Oosterhuis Y, Farrel A, Costes LMM, Joosse ME, van Berkel LA, de Ruiter LF, van Leeuwen MA, Winter D, Holland SM, Freeman AF, Wakabayashi Y, Zhu J, de Ridder L, Driessen GJ, Escher JC, Leonard WJ, Samsom JN.

Mucosal Immunol. 2019 Sep;12(5):1201-1211. doi: 10.1038/s41385-019-0194-9. Epub 2019 Aug 15.

PMID:
31417161
3.

Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort.

Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA.

Inflamm Bowel Dis. 2019 Nov 14;25(12):1927-1938. doi: 10.1093/ibd/izz130.

PMID:
31276165
4.

Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease.

Stapersma L, van den Brink G, van der Ende J, Bodelier AG, van Wering HM, Hurkmans PCWM, Mearin ML, van der Meulen-de Jong AE, Escher JC, Utens EMWJ.

Int J Behav Med. 2019 Aug;26(4):415-426. doi: 10.1007/s12529-019-09791-6.

5.

Complicated disease and response to initial therapy predicts early surgery in paediatric Crohn's disease: results from the Porto Group GROWTH study.

Levine A, Chanchlani N, Hussey S, Ziv-Baran T, Escher JC, Amil Dias J, Veres G, Koletzko S, Turner D, Kolho KL, Paerregaard A, Staiano A, Lionetti P, Nuti F, Sladek M, Shaoul R, Lazowska-Prezeorek I, de Carpi JM, Sigall Boneh R, Pfeffer Gik T, Cohen-Dolev N, Russell RK; Porto Group of ESPGHAN.

J Crohns Colitis. 2019 Jun 3. pii: jjz111. doi: 10.1093/ecco-jcc/jjz111. [Epub ahead of print]

PMID:
31162532
6.

Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.

van den Brink G, Stapersma L, Bom AS, Rizopolous D, van der Woude CJ, Stuyt RJL, Hendriks DM, van der Burg JAT, Beukers R, Korpershoek TA, Theuns-Valks SDM, Utens EMWJ, Escher JC.

Inflamm Bowel Dis. 2019 Nov 14;25(12):1945-1956. doi: 10.1093/ibd/izz073.

PMID:
31050763
7.

Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease.

Cozijnsen MA, Ben Shoham A, Kang B, Choe BH, Choe YH, Jongsma MME, Russell RK, Ruemmele FM, Escher JC, de Ridder L, Koletzko S, Martín-de-Carpi J, Hyams J, Walters T, Griffiths A, Turner D.

Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30372-6. doi: 10.1016/j.cgh.2019.04.012. [Epub ahead of print]

PMID:
30981008
8.

Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study.

van den Brink G, van Gaalen MAC, de Ridder L, van der Woude CJ, Escher JC.

J Crohns Colitis. 2019 Sep 19;13(9):1163-1172. doi: 10.1093/ecco-jcc/jjz044.

PMID:
30766997
9.

IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine.

Costes LMM, Lindenbergh-Kortleve DJ, van Berkel LA, Veenbergen S, Raatgeep HRC, Simons-Oosterhuis Y, van Haaften DH, Karrich JJ, Escher JC, Groeneweg M, Clausen BE, Cupedo T, Samsom JN.

Mucosal Immunol. 2019 Mar;12(2):479-490. doi: 10.1038/s41385-018-0118-0. Epub 2018 Dec 12.

PMID:
30542112
10.

Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function.

de Winter-de Groot KM, Janssens HM, van Uum RT, Dekkers JF, Berkers G, Vonk A, Kruisselbrink E, Oppelaar H, Vries R, Clevers H, Houwen RHJ, Escher JC, Elias SG, de Jonge HR, de Rijke YB, Tiddens HAWM, van der Ent CK, Beekman JM.

Eur Respir J. 2018 Sep 17;52(3). pii: 1702529. doi: 10.1183/13993003.02529-2017. Print 2018 Sep.

PMID:
30166324
11.

Editorial: anxiety and depression in inflammatory bowel disease - authors' reply.

Stapersma L, van den Brink G, Szigethy EM, Escher JC, Utens EMWJ.

Aliment Pharmacol Ther. 2018 Sep;48(6):687-688. doi: 10.1111/apt.14928. No abstract available.

PMID:
30132944
12.

Frequencies of circulating regulatory TIGIT+CD38+ effector T cells correlate with the course of inflammatory bowel disease.

Joosse ME, Menckeberg CL, de Ruiter LF, Raatgeep HRC, van Berkel LA, Simons-Oosterhuis Y, Tindemans I, Muskens AFM, Hendriks RW, Hoogenboezem RM, Cupedo T, de Ridder L, Escher JC, Veenbergen S, Samsom JN.

Mucosal Immunol. 2019 Jan;12(1):154-163. doi: 10.1038/s41385-018-0078-4. Epub 2018 Aug 20.

PMID:
30127383
13.

Systematic review with meta-analysis: anxiety and depression in children and adolescents with inflammatory bowel disease.

Stapersma L, van den Brink G, Szigethy EM, Escher JC, Utens EMWJ.

Aliment Pharmacol Ther. 2018 Sep;48(5):496-506. doi: 10.1111/apt.14865. Epub 2018 Jul 8.

PMID:
29984495
14.

Self-efficacy did not predict the outcome of the transition to adult care in adolescents with inflammatory bowel disease.

van den Brink G, van Gaalen MAC, Zijlstra M, de Ridder L, van der Woude CJ, Escher JC.

Acta Paediatr. 2019 Feb;108(2):333-338. doi: 10.1111/apa.14471. Epub 2018 Jul 10.

15.

Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease.

van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, Hurkmans PCWM, Stuyt RJL, Hendriks DM, van der Burg JAT, Utens EMWJ, Escher JC.

Aliment Pharmacol Ther. 2018 Aug;48(3):358-369. doi: 10.1111/apt.14832. Epub 2018 Jun 13.

PMID:
29897134
16.

Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells.

Schillemans M, Karampini E, van den Eshof BL, Gangaev A, Hofman M, van Breevoort D, Meems H, Janssen H, Mulder AA, Jost CR, Escher JC, Adam R, Carter T, Koster AJ, van den Biggelaar M, Voorberg J, Bierings R.

Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1549-1561. doi: 10.1161/ATVBAHA.117.310701. Epub 2018 Jun 7.

17.

Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Beukers R, Korpershoek TA, Theuns-Valks SDM, Hillegers MHJ, Escher JC, Utens EMWJ.

J Pediatr Psychol. 2018 Oct 1;43(9):967-980. doi: 10.1093/jpepsy/jsy029.

18.

Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero.

de Lima A, Kanis SL, Escher JC, van der Woude CJ.

J Crohns Colitis. 2018 Jul 30;12(8):948-953. doi: 10.1093/ecco-jcc/jjy053.

PMID:
29726943
19.

The impact of Narcotrend™ EEG-guided propofol administration on the speed of recovery from pediatric procedural sedation-A randomized controlled trial.

Weber F, Walhout LC, Escher JC.

Paediatr Anaesth. 2018 May;28(5):443-449. doi: 10.1111/pan.13365. Epub 2018 Mar 25.

PMID:
29575232
20.

Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Apr;66(4):687-708. doi: 10.1097/MPG.0000000000001896.

PMID:
29570147
21.

Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.

Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovszky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D.

J Crohns Colitis. 2018 Apr 27;12(5):630. doi: 10.1093/ecco-jcc/jjx172. No abstract available.

PMID:
29562246
22.

Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.

Levine A, Kori M, Kierkus J, Sigall Boneh R, Sladek M, Escher JC, Wine E, Yerushalmi B, Amil Dias J, Shaoul R, Veereman Wauters G, Boaz M, Abitbol G, Bousvaros A, Turner D.

Gut. 2019 Feb;68(2):239-247. doi: 10.1136/gutjnl-2017-315199. Epub 2018 Feb 2.

PMID:
29420227
23.

Nutrition in Paediatric Inflammatory Bowel Disease: A Position Paper on Behalf of The Porto IBD Group of ESPGHAN.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Jan 29. doi: 10.1097/MPG.0000000000001896. [Epub ahead of print]

PMID:
29384890
24.

Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.

Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Walhout LC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.

PLoS One. 2017 Dec 6;12(12):e0189111. doi: 10.1371/journal.pone.0189111. eCollection 2017.

25.

Less Anti-infliximab Antibody Formation in Paediatric Crohn Patients on Concomitant Immunomodulators.

Kansen HM, van Rheenen PF, Houwen RHJ, Tjon A Ten W, Damen GM, Kindermann A, Escher JC, Wolters VM; Kids with Crohnʼs, Colitis (KiCC) Working Group for Collaborative Paediatric IBD Research in the Netherlands.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):425-429. doi: 10.1097/MPG.0000000000001551.

PMID:
28945207
26.

Disrupted apical exocytosis of cargo vesicles causes enteropathy in FHL5 patients with Munc18-2 mutations.

Vogel GF, van Rijn JM, Krainer IM, Janecke AR, Posovszky C, Cohen M, Searle C, Jantchou P, Escher JC, Patey N, Cutz E, Müller T, Middendorp S, Hess MW, Huber LA.

JCI Insight. 2017 Jul 20;2(14). pii: 94564. doi: 10.1172/jci.insight.94564. eCollection 2017 Jul 20.

27.

Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor.

Veenbergen S, van Leeuwen MA, Driessen GJ, Kersseboom R, de Ruiter LF, Raatgeep RHC, Lindenbergh-Kortleve DJ, Simons-Oosterhuis Y, Biermann K, Halley DJJ, de Ridder L, Escher JC, Samsom JN.

J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):e5-e15. doi: 10.1097/MPG.0000000000001559.

PMID:
28644354
28.

Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.

Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovszky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D.

J Crohns Colitis. 2017 Oct 1;11(10):1230-1237. doi: 10.1093/ecco-jcc/jjx082. Erratum in: J Crohns Colitis. 2018 Apr 27;12(5):630.

PMID:
28605483
29.

Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.

Birimberg-Schwartz L, Zucker DM, Akriv A, Cucchiara S, Cameron FL, Wilson DC, Lazowska I, Yianni L, Paul SP, Romano C, Kolacek S, Buderus S, Pærregaard A, Russell RK, Escher JC, Turner D; Pediatric IBD Porto group of ESPGHAN.

J Crohns Colitis. 2017 Sep 1;11(9):1078-1084. doi: 10.1093/ecco-jcc/jjx053.

PMID:
28430891
30.

European Crohn's and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease.

van Rheenen PF, Aloi M, Biron IA, Carlsen K, Cooney R, Cucchiara S, Cullen G, Escher JC, Kierkus J, Lindsay JO, Roma E, Russell RK, Sieczkowska-Golub J, Harbord M.

J Crohns Colitis. 2017 Sep 1;11(9):1032-1038. doi: 10.1093/ecco-jcc/jjx010.

PMID:
28158494
31.

Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial.

Cozijnsen MA, van Pieterson M, Samsom JN, Escher JC, de Ridder L.

BMJ Open Gastroenterol. 2016 Dec 22;3(1):e000123. doi: 10.1136/bmjgast-2016-000123. eCollection 2016.

32.

Taurolidine in Pediatric Home Parenteral Nutrition Patients.

Hulshof EC, Hanff LM, Olieman J, de Vette S, Driessen GJ, Meeussen C, Escher JC.

Pediatr Infect Dis J. 2017 Feb;36(2):233-235. doi: 10.1097/INF.0000000000001404.

PMID:
27846059
33.

Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.

Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.

Ann Fam Med. 2016 Sep;14(5):437-45. doi: 10.1370/afm.1949.

34.

[Transition from paediatric to adult care: management of adolescents with inflammatory bowel disease].

van den Brink G, van der Woude CJ, de Ridder L, van Gaalen MA, Escher JC.

Ned Tijdschr Geneeskd. 2016;160:D578. Dutch.

PMID:
27581867
35.

Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.

Holtman GA, Lisman-van Leeuwen Y, van Rheenen PF, Kollen BJ, Escher JC, Kindermann A, de Rijke YB, Berger MY.

Fam Pract. 2017 Aug 1;34(4):400-406. doi: 10.1093/fampra/cmw079.

PMID:
27535331
36.

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.

Dekkers JF, Berkers G, Kruisselbrink E, Vonk A, de Jonge HR, Janssens HM, Bronsveld I, van de Graaf EA, Nieuwenhuis EE, Houwen RH, Vleggaar FP, Escher JC, de Rijke YB, Majoor CJ, Heijerman HG, de Winter-de Groot KM, Clevers H, van der Ent CK, Beekman JM.

Sci Transl Med. 2016 Jun 22;8(344):344ra84. doi: 10.1126/scitranslmed.aad8278.

PMID:
27334259
37.

pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.

Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, Romano C, Lionetti P, Hauer AC, Martinez-Vinson C, Veres G, Escher JC, Turner D; paediatric IBD Porto group of ESPGHAN.

Inflamm Bowel Dis. 2016 Aug;22(8):1908-14. doi: 10.1097/MIB.0000000000000784.

PMID:
27135480
38.

Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD).

van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy EM, Utens EM, Escher JC.

BMJ Open Gastroenterol. 2016 Mar 2;3(1):e000071. doi: 10.1136/bmjgast-2015-000071. eCollection 2016.

39.

Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study.

Jansen MA, van den Heuvel D, van der Zwet KV, Jaddoe VW, Hofman A, Escher JC, Fraaij PL, Hooijkaas H, van Zelm MC, Moll HA.

J Pediatr Gastroenterol Nutr. 2016 Oct;63(4):423-30. doi: 10.1097/MPG.0000000000001163.

PMID:
26881413
40.

More Target, More Treatment.

Escher JC.

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):796-7. doi: 10.1097/MPG.0000000000001051. No abstract available.

PMID:
26628443
41.

The Role of Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease.

Joosse ME, Samsom JN, van der Woude CJ, Escher JC, van Gelder T.

Inflamm Bowel Dis. 2015 Sep;21(9):2214-21. doi: 10.1097/MIB.0000000000000420. Review.

PMID:
26284297
42.

Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS Registry.

Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, Lionetti P, Mearin ML, Chong SK, Roma-Giannikou E, Maly J, Kolho KL, Shaoul R, Staiano A, Damen GM, de Meij T, Hendriks D, George EK, Turner D, Escher JC; Paediatric IBD Porto Group of ESPGHAN.

Inflamm Bowel Dis. 2015 Sep;21(9):2145-53. doi: 10.1097/MIB.0000000000000483.

PMID:
26164665
43.

Loss of ADAM17 is associated with severe multiorgan dysfunction.

Bandsma RH, van Goor H, Yourshaw M, Horlings RK, Jonkman MF, Schölvinck EH, Karrenbeld A, Scheenstra R, Kömhoff M, Rump P, Koopman-Keemink Y, Nelson SF, Escher JC, Cutz E, Martín MG.

Hum Pathol. 2015 Jun;46(6):923-8. doi: 10.1016/j.humpath.2015.02.010. Epub 2015 Mar 5.

44.

Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease.

Cozijnsen MA, Escher JC, Griffiths A, Turner D, de Ridder L.

Inflamm Bowel Dis. 2015 Apr;21(4):951-61. doi: 10.1097/MIB.0000000000000245. Review.

PMID:
25723615
45.

Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.

Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.

J Crohns Colitis. 2015 Apr;9(4):305-11. doi: 10.1093/ecco-jcc/jjv031. Epub 2015 Feb 5.

PMID:
25656249
46.

Growth trajectories and bone mineral density in anti-tissue transglutaminase antibody-positive children: the Generation R Study.

Jansen MA, Kiefte-de Jong JC, Gaillard R, Escher JC, Hofman A, Jaddoe VW, Hooijkaas H, Moll HA.

Clin Gastroenterol Hepatol. 2015 May;13(5):913-20.e5. doi: 10.1016/j.cgh.2014.09.032. Epub 2014 Sep 22.

PMID:
25245626
47.

Infant feeding and anti-tissue transglutaminase antibody concentrations in the Generation R Study.

Jansen MA, Tromp II, Kiefte-de Jong JC, Jaddoe VW, Hofman A, Escher JC, Hooijkaas H, Moll HA.

Am J Clin Nutr. 2014 Oct;100(4):1095-101. doi: 10.3945/ajcn.114.090316. Epub 2014 Aug 13.

PMID:
25240074
48.

[Treatment of children with intestinal failure: intestinal rehabilitation, home parenteral nutrition or small intestine transplantation?].

Neelis EG, van Oers HA, Escher JC, Damen GM, Rings EH, Tabbers MM.

Ned Tijdschr Geneeskd. 2014;158:A7771. Review. Dutch.

PMID:
25115209
49.

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martín-de-Carpi J, De Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López VM, Paerregaard A, Russell RK, Serban DE, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D; European Crohn's and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

J Crohns Colitis. 2014 Oct;8(10):1179-207. doi: 10.1016/j.crohns.2014.04.005. Epub 2014 Jun 6.

50.

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.

Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, Levine A, Escher JC, Taminiau J, Veres G, Colombel JF, Vermeire S, Wilson DC, Turner D.

Gut. 2015 Mar;64(3):438-46. doi: 10.1136/gutjnl-2014-307008. Epub 2014 May 12.

PMID:
24821616

Supplemental Content

Loading ...
Support Center